Altered sensitivity to rewarding and aversive drugs in mice with inducible disruption of cAMP response element-binding protein function within the nucleus accumbens

Journal of Neuroscience

Volumn 29, Issue 6, 2009, Pages 1855-1859

  Dinieri, Jennifer A ^a   Nemeth, Christina L ^a   Parsegian, Aram ^a   Carle, Tiffany ^b   Gurevich, Vsevolod V ^c   Gurevich, Eugenia ^c   Neve, Rachael L ^a   Nestler, Eric J ^b,d   Carlezon Jr , William A ^a  

^a MCLEAN HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Aversion; Cocaine; Dysphoria; GRK3; ICSS; K opioid receptors; Reward

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; COCAINE; G PROTEIN COUPLED RECEPTOR KINASE 3; MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; UNCLASSIFIED DRUG;

ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AVERSION; BEHAVIOR CHANGE; BEHAVIOR CONTROL; BRAIN DEPTH STIMULATION; BRAIN FUNCTION; BRAIN REGION; CONTROLLED STUDY; DEPRESSION; DYSPHORIA; FOREBRAIN; GENE ACTIVITY; GENE DISRUPTION; GENE FUNCTION; MALE; MOTIVATION; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RECEPTOR DOWN REGULATION; REWARD; SELF STIMULATION; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; COCAINE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NUCLEUS ACCUMBENS; PROSENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY; REWARD;

EID: 60849109508     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.5104-08.2009     Document Type: Article

References (23)

1. Bals-Kubik R, Ableitner A, Herz A, Shippenberg TS (1993) Neuroanatomi-cal sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J Pharmacol Exp Ther 264:489-495.
2. Barrot M, Olivier JDA, Perrotti LI, DiLeone RJ, Berton O, Eisch AJ, Impey S, Storm DR, Neve RL, Yin JC, Zachariou V, Nestler EJ (2002) CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli. Proc Natl Acad Sci U S A 99:11435-11440.
3. Benovic JL, Gomez J (1993) Molecular cloning and expression of GRK6. A new member of the G protein-coupled receptor kinase family. J Biol Chem 268:19521-19527.
4. Carlezon WA Jr, Chartoff EH (2007) Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Nat Protoc 2:2987-2995.
5. Carlezon WA Jr, Thome J, Olson VG, Lane-Ladd SB, Brodkin ES, Hiroi N, Duman RS, Neve RL, Nestler EJ (1998) Regulation of cocaine reward by CREB. Science 282:2272-2275.
6. Carlezon WA Jr, Duman RS, Nestler EJ (2005) The many faces of CREB. Trends Neurosci 28:436-445.
7. Carlezon WA Jr, Béguin C, DiNieri JA, Baumann MH, Richards MR, Tod-tenkopf MS, Rothman RB, Ma Z, Lee DY, Cohen BM (2006) Depressive-like effects of the K-opioid receptor agonist Salvinorin A on behavior and neurochemistry in rats. J Pharmacol Exp Ther 316:440-447.
8. Dong Y, Green T, Saal D, Marie H, Neve R, Nestler EJ, Malenka RC (2006) CREB modulates excitability of nucleus accumbens neurons. Nat Neuro-sci 9:475-477.
9. Gilliss B, Malanga CJ, Pieper JO, Carlezon WA Jr (2002) Cocaine and SKF-82958 potentiate brain stimulation reward in Swiss-Webster mice. Psy-chopharmacology (Berl) 163:238-248.
10. Mague SD, Pliakas AM, Todtenkopf MS, Tomasiewicz HC, Zhang Y, Stevens WC Jr, Jones RM, Portoghese PS, Carlezon WA Jr (2003) Antidepressant-like effects of K-opioid receptor antagonists in the forced swim test in rats. J Pharmacol Exp Ther 305:323-330.
11. McClung CA, Nestler EJ (2003) Regulation of gene expression and cocaine reward by CREB and DFosB. Nat Neurosci 6:1208-1215.
12. McLaughlin JP, Myers LC, Zarek PE, Caron MG, Lefkowitz RJ, Czyzyk TA, Pintar JE, Chavkin C (2004) Prolonged K-opioidreceptorphosphoryla-tion mediated by G-protein receptor kinase underlies sustained analgesic tolerance. J Biol Chem 279:1810-1818.
13. Nestler EJ, Carlezon WA Jr (2006) The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 59:1151-1159.
14. Newton SS, Thome J, Wallace TL, Shirayama Y, Schlesinger L, Sakai N, Chen J, Neve R, Nestler EJ, Duman RS (2002) Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect. J Neurosci 22:10883-10890.
15. Pliakas AM, Carlson RR, Neve RL, Konradi C, Nestler EJ, Carlezon WA Jr (2001) Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in the nucleus accumbens. J Neurosci 21:7397-7403.
16. Sakai N, Thome J, Newton SS, Chen J, Kelz MB, Steffen C, Nestler EJ, Duman RS (2002) Inducible and brain region-specific CREB transgenic mice. Mol Pharmacol 61:1453-1464.
17. Svingos AL, Colago EE, Pickel VM (1999) Cellular sites for dynorphin activation of K-opioid receptors in the rat nucleus accumbens shell. J Neuro-sci 19:1804-1813.
18. Todtenkopf MS, Parsegian A, Naydenov A, Neve RL, Konradi C, Carlezon WAJr (2006) Brain reward regulated by AMPA receptor subunits in the nucleus accumbens shell. J Neurosci 26:11665-11669.
19. Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ (2006) Sustained hippocampal chromatin regulation in hippocampus in a mouse model ofdepression and antidepressant action. Nat Neurosci 9:519-525.
20. Turgeon SM, Pollack AE, Fink JS (1997) Enhanced CREB phosphorylation and changes in c-Fos and FRA expression in striatum accompany amphetamine sensitization. Brain Res 749:120-126.
21. Wadenberg ML (2003) A review of the properties of spiradoline: a potent and selective kappa-opioid receptor agonist. CNS Drug Rev9:187-198.
22. Walters CL, Godfrey M, Li X, Blendy JA (2005) Alterations in morphine-induced reward, locomotor activity, and thermoregulation in CREB-deficient mice. Brain Res 1032:193-199.
23. West TE, Wise RA (1988) Effects of naltrexone on nucleus accumbens, lateral hypothalamic and ventral tegmental self-stimulation rate-frequency functions. Brain Res 462:126-133.